Literature DB >> 33037073

Leptin modulates pancreatic β-cell membrane potential through Src kinase-mediated phosphorylation of NMDA receptors.

Veronica A Cochrane1, Yi Wu1, Zhongying Yang1, Assmaa ElSheikh2, Jeremy Dunford3, Paul Kievit4, Dale A Fortin5, Show-Ling Shyng6.   

Abstract

The adipocyte-derived hormone leptin increases trafficking of KATP and Kv2.1 channels to the pancreatic β-cell surface, resulting in membrane hyperpolarization and suppression of insulin secretion. We have previously shown that this effect of leptin is mediated by the NMDA subtype of glutamate receptors (NMDARs). It does so by potentiating NMDAR activity, thus enhancing Ca2+ influx and the ensuing downstream signaling events that drive channel trafficking to the cell surface. However, the molecular mechanism by which leptin potentiates NMDARs in β-cells remains unknown. Here, we report that leptin augments NMDAR function via Src kinase-mediated phosphorylation of the GluN2A subunit. Leptin-induced membrane hyperpolarization diminished upon pharmacological inhibition of GluN2A but not GluN2B, indicating involvement of GluN2A-containing NMDARs. GluN2A harbors tyrosine residues that, when phosphorylated by Src family kinases, potentiate NMDAR activity. We found that leptin increases phosphorylation of Tyr-418 in Src, an indicator of kinase activation. Pharmacological inhibition of Src or overexpression of a kinase-dead Src mutant prevented the effect of leptin, whereas a Src kinase activator peptide mimicked it. Using mutant GluN2A overexpression, we show that Tyr-1292 and Tyr-1387 but not Tyr-1325 are responsible for the effect of leptin. Importantly, β-cells from db/db mice, a type 2 diabetes mouse model lacking functional leptin receptors, or from obese diabetic human donors failed to respond to leptin but hyperpolarized in response to NMDA. Our study reveals a signaling pathway wherein leptin modulates NMDARs via Src to regulate β-cell excitability and suggests NMDARs as a potential target to overcome leptin resistance.
© 2020 Cochrane et al.

Entities:  

Keywords:  GluN2A; KATP channel; Src; Src kinase; beta cell (B-cell); glutamate receptor; phosphorylation; type 2 diabetes; β-cells

Mesh:

Substances:

Year:  2020        PMID: 33037073      PMCID: PMC7863909          DOI: 10.1074/jbc.RA120.015489

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  The actions of synaptically released zinc at hippocampal mossy fiber synapses.

Authors:  K Vogt; J Mellor; G Tong; R Nicoll
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

Review 2.  Selective insulin and leptin resistance in metabolic disorders.

Authors:  A Christine Könner; Jens C Brüning
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

Review 3.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.

Authors:  Pierre Paoletti; Camilla Bellone; Qiang Zhou
Journal:  Nat Rev Neurosci       Date:  2013-06       Impact factor: 34.870

Review 4.  The adipoinsular axis: effects of leptin on pancreatic beta-cells.

Authors:  T J Kieffer; J F Habener
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-01       Impact factor: 4.310

5.  The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis.

Authors:  Scott D Covey; Rhonda D Wideman; Christine McDonald; Suraj Unniappan; Frank Huynh; Ali Asadi; Madeleine Speck; Travis Webber; Streamson C Chua; Timothy J Kieffer
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

6.  NMDA receptors mediate leptin signaling and regulate potassium channel trafficking in pancreatic β-cells.

Authors:  Yi Wu; Dale A Fortin; Veronica A Cochrane; Pei-Chun Chen; Show-Ling Shyng
Journal:  J Biol Chem       Date:  2017-08-02       Impact factor: 5.157

7.  YES, a Src family kinase, is a proximal glucose-specific activator of cell division cycle control protein 42 (Cdc42) in pancreatic islet β cells.

Authors:  Stephanie M Yoder; Stacey L Dineen; Zhanxiang Wang; Debbie C Thurmond
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

8.  The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts.

Authors:  Olivier Destaing; Archana Sanjay; Cecile Itzstein; William C Horne; Derek Toomre; Pietro De Camilli; Roland Baron
Journal:  Mol Biol Cell       Date:  2007-10-31       Impact factor: 4.138

9.  Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus.

Authors:  J Seufert; T J Kieffer; C A Leech; G G Holz; W Moritz; C Ricordi; J F Habener
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

10.  Recovery of viable endocrine-specific cells and transcriptomes from human pancreatic islet-engrafted mice.

Authors:  Sambra D Redick; Linda Leehy; Ann R Rittenhouse; David M Blodgett; Alan G Derr; Alper Kucukural; Manuel G Garber; Leonard D Shultz; Dale L Greiner; Jennifer P Wang; David M Harlan; Rita Bortell; Agata Jurczyk
Journal:  FASEB J       Date:  2019-12-10       Impact factor: 5.191

View more
  4 in total

1.  Leptin promotes striatal dopamine release via cholinergic interneurons and regionally distinct signaling pathways.

Authors:  Maria Mancini; Jyoti C Patel; Alison H Affinati; Paul Witkovsky; Margaret E Rice
Journal:  J Neurosci       Date:  2022-07-20       Impact factor: 6.709

Review 2.  Posttranslational modifications in diabetes: Mechanisms and functions.

Authors:  Bin Chen; Jianing Zhong; Ang Hu; Haohong Zou
Journal:  Rev Endocr Metab Disord       Date:  2022-06-13       Impact factor: 9.306

Review 3.  Subcellular trafficking and endocytic recycling of KATP channels.

Authors:  Hua-Qian Yang; Fabio A Echeverry; Assmaa ElSheikh; Ivan Gando; Sophia Anez Arredondo; Natalie Samper; Timothy Cardozo; Mario Delmar; Show-Ling Shyng; William A Coetzee
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-04       Impact factor: 5.282

Review 4.  Recent evidence in support of traditional chinese medicine to restore normal leptin function in simple obesity.

Authors:  Jialin Shao; Chen Li; Litao Bai; Xiaolin Ni; Shaoqin Ge; Jinghui Zhang; Hanqing Zhao
Journal:  Heliyon       Date:  2022-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.